Kingsley Stuart A

SEC Form 4 insider trading activity

Kingsley Stuart A has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: May 14, 2026.

On the most recent filing, Kingsley Stuart A is listed as Director at Indivior Pharmaceuticals, Inc. Inside the rolling window, Kingsley Stuart A reported 1 open-market purchase totaling $30K in INDV and no open-market sales.

Companies traded

Other insiders at INDV

Insider Buying

$30K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
INDV
Kingsley Stuart A
Purchase$30KMar 11SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Kingsley Stuart A made?

Kingsley Stuart A has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.

Which companies does Kingsley Stuart A trade?

Kingsley Stuart A has filed SEC Form 4 disclosures for 1 company, including INDV.

When was Kingsley Stuart A's most recent SEC Form 4 filing?

Kingsley Stuart A's most recent SEC Form 4 filing on Tracefour is dated May 14, 2026.

What is Kingsley Stuart A's total buy and sell value in the current window?

Inside the rolling retention window, Kingsley Stuart A bought $30K and sold $0 based on SEC Form 4 filings.

What was Kingsley Stuart A's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 940 INDV shares on 2026-03-06, worth $30K, per SEC Form 4 filings.